A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-017-1972-x

PubMed Identifier: 28587616

Publication URI: http://europepmc.org/abstract/MED/28587616

Type: Journal Article/Review

Volume: 18

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215